טוען...
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
OBJECTIVE: To assess the long-term safety, tolerability, and efficacy of fremanezumab, a fully humanized monoclonal antibody approved for the preventive treatment of migraine. METHODS: A 52-week, multicenter, randomized, double-blind, parallel-group study evaluated fremanezumab monthly or quarterly...
שמור ב:
| הוצא לאור ב: | Neurology |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7682830/ https://ncbi.nlm.nih.gov/pubmed/32913018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010600 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|